Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 48Recruiting 20Unknown 13Active not recruiting 10Not yet recruiting 7Withdrawn 6Terminated 6Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Recurrence 2Prostatic Neoplasms 1Myofibroma 1Multiple Myeloma 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leiomyoma 1Insulin Resistance 1Endometriosis 1Dementia 1Cognitive Dysfunction 1Alzheimer Disease 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Withdrawn × Tablets × Clear all
NCT05568940 2024-05-30

eTAPE

McGill University Health Centre/Research Institute of the McGill University Health Centre

Withdrawn

Endometriosis, Leiomyoma

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

St. Louis University

Phase EARLY_PHASE1 Withdrawn
Genitourinary

Insulin Resistance, Prostatic Neoplasms

NCT05330377 2023-04-25

GM-CLAG in Relapsed/Refractory FLT3-mutated AML

University of Kentucky

Phase 1 Withdrawn
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Boston University

Phase NA Withdrawn
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT03156127 2017-08-10

A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

Boryung Pharmaceutical Co., Ltd

Phase 1 Withdrawn

Myofibroma

NCT02756663 2016-11-08

PANORAMA-5

Novartis

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡